Chikungunya Fever Market Market Research Future published a half-cooked research report on global chikungunya fever market. Which is Estimated to Grow at a CAGR over 5.86% - Forecast to 2023
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is no specific antiviral drug treatment for Chikungunya. Treatment is directed primarily at relieving the symptoms. This involves use of anti-pyretics, optimal analgesics in allopathy. Moreover, ayurveda and homeopathy can be employed in the treatment procedures. According to the World Health Organization, the disease mostly occurs in Africa, Asia and the Indian subcontinent. However a major outbreak in 2015 affected several countries of the region of the Americas. This is expected to boost the market growth across the globe during the forecasted period.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/4694 .
Top Key Players are - Quest Diagnostics Incorporated. (U.S.A), Alere. (U.S.A), Genome Diagnostics Pvt. Ltd. (India), altona Diagnostics (Europe), Bio-Rad Laboratories, Inc. (U.S.A), Sanat Products Ltd. (India), Taj Pharmaceuticals Limited. (India), and Etubics Corporation (U.S.A).
The Americas dominate the global chikungunya fever market owing to a large patient population, strong government support for research & development, and high healthcare spending. Moreover, presence of the global market leaders within the regions facilitates the market growth within the region during the forecasted period.
Europe has the second leading market in global chikungunya fever market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for chikungunya fever. On 22 September 2017, according to the European Centre for Disease Prevention and Control there were about 102 autochthonous chikungunya cases in Italy. Moreover, similar cases were reported in France. Such factors in the presence of a well-developed healthcare infrastructure along with high per capita healthcare expenditures made Europe to generate high revenues for the global chikungunya fever market. Asia Pacific chikungunya fever market is majorly driven by Indian and China owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market.
The Middle East and Africa contribute the least in the growth of global chikungunya fever market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to the presence of opportunities for the development of the market.
Browse complete report at https://www.marketresearchfuture.com/reports/chikungunya-fever-market-4694 .
LIST OF TABLES
Table 1 Chikungunya Fever Industry Synopsis, 2017 – 2023
Table 2 Global Chikungunya Fever Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Chikungunya Fever Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)
Table 5 Global Chikungunya Fever Market By Treatment, 2017 – 2023, (USD Million)
Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/4694 .
Table 6 Global Chikungunya Fever Market By End Users, 2017 – 2023, (USD Million)
Table 7 North America Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)
Table 8 North America Chikungunya Fever Market By Treatment, 2017 – 2023, (USD Million)
Table 9 North America Chikungunya Fever Market By End Users, 2017 – 2023, (USD Million)
Table 10 US Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)
Table 11 US Chikungunya Fever By Treatment, 2017 – 2023, (USD Million)
Table 12 US Chikungunya Fever By End Users, 2017 – 2023, (USD Million)
Table 13 Canada Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/chikungunya-fever-market-4694
Source: www.abnewswire.com
